Showing 6631-6640 of 20413 results for "".
Doctors:Unwilling Pawns in Healthcare Finance Game
https://reachmd.com/programs/revealing-retina/doctorsunwilling-pawns-in-healthcare-finance-game/2772/Dr. Roy Levit welcomes Dr. Michael Newton, Medical Ethicist and an Ophthalmologist specializing in corneal disease and transplantation. They will dicuss Dr. Newton's book, "Without Your Consent, The Hijacking of American Health Care". They will cover all of the outside influences from managed care tHope: A Complement to Cancer Treatment
https://reachmd.com/programs/clinicians-roundtable/hope-a-complement-to-cancer-treatment/2756/When it comes to cancer care, we know about chemotherapy, surgery, bone marrow transplants and even the coming of stem cell therapies. But should hope also be included as a treatment for these life threatening diseases? Dr. Edgar Staren, senior vice president for clinical affairs and chief medical oWhy We'll Never Cure Cancer?
https://reachmd.com/programs/clinicians-roundtable/why-well-never-cure-cancer/2389/What is keeping our society from moving forward in our ability to cure disease? How can what is learned in the lab be brought to the frontlines more quickly and efficiently? How can individual medical institutions work together to make a more profound difference in our healthcare system? Our GuestDiagnosing and Treating CF: What is new?
https://reachmd.com/programs/clinicians-roundtable/diagnosing-and-treating-cf-what-is-new/2099/Our guest Dr. Rick Moss discuses with host, Dr. Bill Rutenberg current modes of diagnosis, including the genetic basis of CF. This is followed by a discussion of current and future treatments for cystic fibrosis, including lung transplantation, stem cell and gene therapies.Challenges in Treating Polycystic Ovarian Syndrome
https://reachmd.com/programs/advances-in-womens-health/challenges-in-treating-polycystic-ovarian-syndrome/1879/Anovulation is a significant challenge for reproductive age women. The most common endocrinologic cause of this is PCOS. With the help of Dr. Sam Thatcher, pioneer in IVF technology and director of the Center for Applied Reproductive Science, we explore the exciting new possibilities and not-so-newGuiding a Department Through 9/11 in NYC
https://reachmd.com/programs/clinicians-roundtable/guiding-a-department-through-911-in-nyc/1431/Host Dr. Shira Johnson talks with Dr. Michael Sadler, section chief of the division of body CT at St. Vincent's Hospital Manhattan in downtown New York City, about his hospital's preparedness for 9/11 and its aftermath.Novel Therapies for HDL Cholesterol
https://reachmd.com/programs/clinicians-roundtable/novel-therapies-for-hdl-cholesterol/818/Will novel HDL cholesterol therapies reduce cardiovascular risk? Dr. Robert Rosenson will discuss the hope for CETP inhibitors and HDL mimetics to modify HDL cholesterol and coronary heart disease risk.Evolving Safety Considerations in Atopic Dermatitis Management
https://reachmd.com/programs/dermconsult/safety-atopic-dermatitis-management/60653/As treatment options for atopic dermatitis continue to expand, it's vital to carefully balance efficacy, safety, and patient concerns when developing individualized care plans. On this episode, Dr. Peter Lio reviews the evolving safety profiles of biologics and JAK inhibitors, discusses the continueAllergic Comorbidities in Atopic Dermatitis: What the Evidence Shows
https://reachmd.com/programs/dermconsult/allergic-comorbidities-atopic-dermatitis-evidence/60652/Food allergy, eosinophilic esophagitis, and other allergic conditions frequently intersect with atopic dermatitis, but misconceptions about prevention and management are common. That's why Dr. Lawrence Eichenfield joins us to share the latest American Academy of Dermatology guidance on allergic comoAdvancing Alopecia Care: The Changing Treatment Landscape
https://reachmd.com/programs/dermconsult/alopecia-changing-treatment-landscape/56528/The management of alopecia has undergone a remarkable transformation in recent years, creating new opportunities to improve outcomes for patients with both inflammatory and non-inflammatory hair loss disorders. To learn more about the evolving treatment landscape, we recently spoke with Dr. Benjamin